 |
Back to home »
Top Stories
» ICAAC 2007
  
Coming Down the Pike: Expanding HIV Treatment Options
September 19, 2007
Peter Staley asks Dr. Joe Eron about the latest data from the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) on soon-to-be-approved Isentress and another integrase inhibitor called elvitegravir, and an entry inhibitor you might inject just once every other week.
NEW! Scroll down to comment on this story.
Previous Comments:
comments 1 - 2 (of 2 total)
Dennis, Albuquerque, 2007-09-20 21:14:46
I sometime have I allergic reactions to FUZEON injections and NIASPAN most of the time it's so bad I have to take DPHENHYDRAME to stop the Hives & the icthy needle stick injection sites, is Pro140 something I should ask my HIV Doctor about? and would I benefit fron taking Pro140?
Thanks for your time!
Al, , 2007-09-19 17:53:02
Pro140? I was giving myself injections of Fuzeion and I stopped because, I had allergic reactions to it. Now, Im not taking anything. Will Pro140 give you physical side effects, like the lypo's, and will it work for me since I stopped the Fuzeion. Thanks, Al Oakes, Jr.
comments 1 - 2 (of 2 total)
[Go to top]
|
|
|
Peter Staley asks Dr. Sharon Walmsley what women need to know about HIV and antivirals, and gender differences needing more research.
Peter Staley asks Dr. Joe Eron about the latest data on soon-to-be-approved Isentress and an entry inhibitor you might inject just once every other week.
Peter Staley asks Dr. Joe Eron about the good news on a challenging drug -- newly-approved Selzentry -- and the very potent new protease inhibitor, Prezista.
Peter Staley talks with Matt Sharp about his activism, his new regimen, and his facial lipo fix.
Peter Staley interviews Jules Levin, an activist and survivor of hepatitis C and HIV coinfection, about the latest in HCV treatment and prevention.